David J. Greenblatt, M.D.
VP Research & Innovation
Professor, Tufts University School of Medicine
A native of Newton, Massachusetts, Dr. Greenblatt is a Magna Cum Laude graduate of Amherst College (1966), where he was senior class president and co-captain of the varsity football team. He attended Harvard Medical School, graduating in 1970. He trained in internal medicine at the Montefiore Hospital, New York City (1970-1971), and on the Harvard Medical Service at Boston City Hospital (1971-1972). Following a Fellowship in Clinical Pharmacology at Massachusetts General Hospital, under the mentorship of Dr. Jan Koch-Weser (1972-1974), he stayed on to head their Clinical Pharmacology Unit (1975-1979).
Dr. Greenblatt has been on the Faculty of Tufts University School of Medicine (TUSM) and the Staff of Tufts Medical Center (TMC) since 1979. He holds the Louis Lasagna, M.D., Endowed Professorship at TUSM in the Department of Immunology (formerly the Department of Pharmacology and Experimental Therapeutics), and is a senior faculty member in the Graduate Program in Pharmacology & Experimental Therapeutics at the School of Graduate Biomedical Sciences at Tufts University. He also holds appointments as Professor of Psychiatry, Medicine, and Anesthesia, at TUSM. He has previously served as Chair of the Department of Pharmacology and Experimental Therapeutics at TUSM, Program Director and Associate Program Director of the institution’s Clinical/Translational Research Center and Chair of the Institutional Review Board. He is Editor-in-Chief of Clinical Pharmacology in Drug Development. He also served as Co-Editor-in-Chief, with Dr. Richard I. Shader, of the Journal of Clinical Psychopharmacology, (1981 – 2020). His PubMed listing includes over 1000 publications; more than 780 representing original research reports. His work has been supported by the National Institutes of Health for over 35 years. Dr. Greenblatt served on many NIH study sections and advisory groups. He has served as postdoctoral training supervisor or dissertation supervisor for over 50 trainees, most of whom have gone on to positions as university-based investigators or scientists in industry.
Dr. Greenblatt is Board Certified by the American Board of Clinical Pharmacology (1991), where he is a charter member. Dr. Greenblatt has been a member of the American Society for Clinical Pharmacology and Therapeutics since the 1970s and received the Rawls-Palmer Award from that organization in 1980. As a member of the American College of Clinical Pharmacology (ACCP) since the 1970s, he served as President (1996 -1998), and received their McKeen-Cattell Award in 1985, the Distinguished Service Award in 2001, and the Distinguished Investigator Award in 2002. He received the 2005 Research Achievement Award in Clinical Sciences from the American Association of Pharmaceutical Sciences. Dr. Greenblatt received an Outstanding Speaker Award from the American Association for Clinical Chemistry in 2013, and the Distinguished Faculty Award from TUSM in 2015. Dr. Greenblatt was the recipient of the 2016 Award in Excellence in Clinical Pharmacology from the Pharmaceutical Research and Manufacturers of America Foundation, through the American Society for Clinical Pharmacology and Therapeutics. Also in 2016, he received the Man of Good Conscience Award from the Association of Women Psychiatrists.